Photodynamic Therapy for Eye Cancer
Ocular Oncology Service, Royal Hallamshire Hospital, Sheffield S10 2JF, UK
Biomedicines 2017, 5(4), 69; https://doi.org/10.3390/biomedicines5040069
Received: 22 October 2017 / Revised: 26 November 2017 / Accepted: 4 December 2017 / Published: 8 December 2017
(This article belongs to the Special Issue Photodynamic Therapy in Cancer)
Photodynamic therapy is well-established as a treatment for a number of conditions in ophthalmology, principally in the field of medical retina, but less so in ocular oncology. Cancer of the eye is rare, the commonest lesions to affect the globe being choroidal melanoma (as a primary malignancy) and choroidal metastases (a secondary malignancy). The mainstay of treatment of such lesions remains radiotherapy in various forms, however, photodynamic therapy does have a useful role to play in the management of such patients. In this article, I hope to review the current indications, treatment regimes, and the risks and benefits of photodynamic therapy (PDT) as a treatment for eye cancer. View Full-Text
Keywords: photodynamic therapy; photodynamic therapy; uvea; melanoma; metastasis; choroid; eye; cancer►▼ Show Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Rundle, P. Photodynamic Therapy for Eye Cancer. Biomedicines 2017, 5, 69.
AMA StyleShow more citation formats Show less citations formats
Rundle P. Photodynamic Therapy for Eye Cancer. Biomedicines. 2017; 5(4):69.Chicago/Turabian Style
Rundle, Paul. 2017. "Photodynamic Therapy for Eye Cancer." Biomedicines 5, no. 4: 69.
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.